Zusammenfassung
Typ-2-Diabetes und Adipositas sind pathophysiologisch eng verknüpft. Dies spiegelt sich im Begriff des metabolischen Syndroms wider, mit dem das gemeinsame Vorliegen von Glukoseintoleranz, stammbetonter Adipositas, arterieller Hypertonie und Dyslipidämie beschrieben wird. Patienten mit Typ-2-Diabetes entwickeln häufiger bösartige Tumoren von Kolon/Rektum, Pankreas, Leber, Mamma und Endometrium. Unabhängig von einer Diabetesmanifestation sind Übergewicht und Adipositas ebenfalls mit einer Häufung von Krebserkrankungen assoziiert. Auch die Mortalität durch Krebs ist erhöht. Die zugrunde liegenden Pathomechanismen, die das erhöhte Krebsrisiko erklären könnten, sind Gegenstand aktueller Forschung. Als mögliche Faktoren werden Hyperinsulinämie, Mediatoren aus Fettzellen wie Adipokine, Sexualhormone, chronische Inflammation und oxidativer Stress diskutiert. In Anbetracht der enormen und weiterhin steigenden Prävalenz von Typ-2-Diabetes und Übergewicht/Adipositas muss das potenziell erhöhte Krebsrisiko intensiv in den Fokus von Forschung und Klinik gerückt werden.
Abstract
Type 2 diabetes mellitus and obesity are pathophysiologically closely related. This is revealed in the complex entity of metabolic syndrome, which describes the simultaneous occurence of glucose intolerance, obesity, arterial hypertension, and dyslipidemia. Patients with type 2 diabetes mellitus show an increased frequency of colorectal, pancreatic, liver, breast and endometrial cancer. Independent of diabetes manifestation, an increase of malignancies has been reported in obesity, and also mortality due to cancer is increased. The underlying pathophysiology is currently under investigation and potential factors under study include hyperinsulinemia, adipokines, sex hormones, chronic inflammation and oxidative stress. Considering the enormous and further accelerating increase of type 2 diabetes mellitus and overweight the potential enhanced risk of cancer needs to be carefully addressed in research and clinical aspects.
Literatur
World Health Organization (2011) Global status report on noncommunicable diseases 2010. http://www.who.int/nmh/publications/ncd_report2010/en/. Zugegriffen: 25. Mai. 2012
Adams TD, Stroup AM, Gress RE et al (2009) Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 17:796–802
Atchison EA, Gridley G, Carreon JD et al (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128:635–643
Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764
Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928–1937
Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638
Cornier MA, Dabelea D, Hernandez TL et al (2008) The metabolic syndrome. Endocr Rev 29:777–822
Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273:1605–1609
Federico A, Morgillo F, Tuccillo C et al (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381–2386
Ferlay J, Shin H, Bray F et al (2010) GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10. International Agency for Research on Cancer, Lyon, France
Friberg E, Orsini N, Mantzoros CS et al (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374
Gallagher EJ, Leroith D (2011) Minireview: IGF, insulin, and cancer. Endocrinology 152:2546–2551
Gapstur SM, Gann PH, Lowe W et al (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552–2558
Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg) (2012) Krebs in Deutschland 2007/2008, 8. Ausgabe. Robert Koch-Institut, Berlin
Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685
Hemminki K, Li X, Sundquist J et al (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548–555
Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:2056–2062
Kelly T, Yang W, Chen CS et al (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32:1431–1437
Kushi LH, Doyle C, Mccullough M et al (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62:30–67
Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862
Larsson SC, Orsini N, Brismar K et al (2006) Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 49:2819–2823
Park J, Euhus DM, Scherer PE (2011) Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 32:550–570
Pollak M (2012) The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 12:159–169
Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486
Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316
Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847–853
Sjostrom L, Gummesson A, Sjostrom CD et al (2009) Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 10:653–662
Vigneri P, Frasca F, Sciacca L et al (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123
Whiting DR, Guariguata L, Weil C et al (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321
Whitlock G, Lewington S, Sherliker P et al (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096
World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC
Wrann CD, Laue T, Hubner L et al (2012) Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions. Am J Physiol Endocrinol Metab 302:E108–116
Yang WS, Va P, Bray F et al (2011) The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One 6:e27326
Yuhara H, Steinmaus C, Cohen SE et al (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106:1911–1921
Interessenkonflikt
Die korrespondierende Autorin gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Heer, J. Adipositas, metabolisches Syndrom und Krebsentstehung. Diabetologe 8, 455–462 (2012). https://doi.org/10.1007/s11428-012-0864-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-012-0864-7